Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Metabolic convergence on TOR signaling in the chestnut blight fungus and its regulation by host plant signals.

Created on 14 Oct 2026

Authors

Yo-Han Ko, Jeesun Chun, Geonmin Kim, Jiwon Yu, Dae-Hyuk Kim

Published in

The New phytologist. Oct 13, 2026. Epub Oct 13, 2026.

Abstract

Transcriptomic analysis of the chestnut blight fungus Cryphonectria parasitica identified 22 core genes regulated by Cryphonectria hypovirus 1 (CHV1) infection and sectorization. Twelve genes with common phenocopies were analyzed: all mutants displayed restricted colonial growth, intense pigmentation, hyperbranched terminal hyphae with swollen globose cells, and reduced conidiation. Although gene-specific mutant phenotypes existed, responses to most stressors were similar to those of the wild-type. Mutant growth was highly sensitive to nutrient conditions, and growth restriction was notably alleviated by supplementation with 1.0 M sorbitol, nutrient-deficient media, or skim milk. All mutants showed hallmarks consistent with reduced target of rapamycin (TOR) signaling. Trehalose accumulation, a canonical fungal response to TOR inhibition, was observed in mutants via transcriptional upregulation of core trehalose biosynthetic genes, resulting in altered hyphal osmolarity and common mutant cell phenotypes. Plant signals overrode the mutants' phenotypes, strongly promoting their growth and differentiation. Although a severely retarded growth defect was observed in mutants, mutants' virulence remained intact, which can be ascribed to the host-plant signals. Cryphonectria hypovirus 1 (CHV1)-infected mutants exhibited greater growth restriction, accompanied by genotype-specific CHV1 titers. Despite gene-specific variation, common phenocopies indicate that diverse metabolic pathways converge on the TOR pathway in the fungal response to host-plant and CHV1 infection.

PMID:
42870285
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement